[Immunoenzyme determination of fibrin-fibrinogen degradation product levels in acute myocardial infarct patients].
The changes in the blood level of fibrin-fibrinogen degradation products (FDP) have been studied in 62 patients with myocardial infarction. 30 healthy donors served as the control. FDP was determined using solid-phase immunoenzyme assay. Acute and subacute phases of myocardial infarction were characterized by an increase in FDP blood level. However, in severe cases a possible low FDP blood level in conditions of fibrinolysis depression may be associated with an increased risk of severe thromboembolic complications.
Grinshteĭn
I A
IA
Ignashenkova
G V
GV
Kitaev
M I
MI
D005338:Fibrin Fibrinogen Degradation Products / Q000032:analysis*; D005342:Fibrinolysis; D006801:Humans; D007124:Immunoenzyme Techniques; D009203:Myocardial Infarction / Q000097:blood*; D013997:Time Factors
D005338:Fibrin Fibrinogen Degradation Products
Immunofermentnoe opredelenie kontsentratsii produktov degradatsii fibrin-fibrinogena u bol'nykh ostrym infarktom miokarda.